New York, NY – Shares of biotechnology leader Regeneron Pharmaceuticals, Inc. (Ticker: REGN) experienced a slight uptick in today’s trading session on the Nasdaq Stock Market. As of 22:28 GMT+5:30, the REGN stock price stood at 487.64 USD, a gain of +2.71 USD or +0.56% for the day. The 1-day performance summary also shows a +0.57% increase.
This minor daily positive movement offers a brief respite from a period of more challenging performance for the pharmaceutical stock. REGN shares have declined -5.79% over the past 5 days, -18.85% over the last month, -36.55% over six months, -32.34% year-to-date (YTD), -50.91% over the past year, and -16.63% over the past five years.
The previous closing price for REGN was 484.93 USD. The intraday REGN chart showed initial volatility with a dip, followed by a rally and then some consolidation. Despite the recent and medium-term downturns, the all-time performance for Regeneron Pharmaceuticals remains exceptionally strong, with a remarkable gain of +2,210% (2.21K%).
Regeneron, known for its innovative medicines in areas like eye diseases, allergic and inflammatory diseases, cancer, and cardiovascular diseases, has been a significant player in the biotechnology sector. Investors will be watching to see if today’s modest gain signals a potential stabilization or turning point after a prolonged period of negative returns, or if it’s merely a minor fluctuation within the broader downward trend.
Frequently Asked Questions (FAQ) about Regeneron Pharmaceuticals, Inc. (REGN) Stock
Q1: What is the current stock price of Regeneron Pharmaceuticals, Inc.?
A: As of the latest update (today at 22:28 GMT+5:30), the stock price for Regeneron Pharmaceuticals, Inc. is 487.64 USD.
Q2: What is the stock ticker symbol for Regeneron Pharmaceuticals, Inc.?
A: The stock ticker symbol is REGN.
Q3: On which stock exchange is Regeneron Pharmaceuticals, Inc. (REGN) traded?
A: Regeneron Pharmaceuticals, Inc. (REGN) is traded on the Nasdaq Stock Market.
Q4: How has Regeneron’s stock (REGN) performed today?
A: As of 22:28 GMT+5:30, the stock has increased by +2.71 USD, which is a +0.56% gain. The 1-day performance summary shows +0.57%.
Q5: What is the recent and long-term performance of Regeneron stock?
A:
-
1 Day: +0.57%
-
5 Days: -5.79%
-
1 Month: -18.85%
-
6 Months: -36.55%
-
Year to Date (YTD): -32.34%
-
1 Year: -50.91%
-
5 Years: -16.63%
-
All Time: +2,210% (2.21K%)
Q6: What was the previous closing price for Regeneron (REGN) stock?
A: The previous closing price was 484.93 USD.
Q7: What does Regeneron Pharmaceuticals, Inc. do?
A: Regeneron Pharmaceuticals, Inc. is a leading biotechnology company that invents, develops, manufactures, and commercializes medicines for serious medical conditions. Their products target areas such as eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, and rare diseases.
Q8: Why is Regeneron’s stock showing a significant decline over the past year and 5 years, despite a very strong all-time performance?
A: The biotechnology and pharmaceutical sectors can be highly volatile. Declines over periods like 1-year or 5-years can be due to various factors such as clinical trial results, patent expirations, increased competition, regulatory changes, or shifts in market sentiment towards the sector. The very strong “All time” performance indicates that, historically, the company has delivered significant growth and value, but it has faced more recent headwinds. Today’s slight gain is a minor positive against this recent backdrop.
Q9: Where can I find more detailed chart information for REGN stock?
A: The image indicates options to view a “Full chart” or “See on Supercharts.” These buttons typically link to advanced financial charting platforms where you can conduct a more in-depth analysis of the REGN stock price, historical trends, and relevant market data.
